Jury Still Out On Success Of FDA's Warning Letter Close-Out Program
This article was originally published in The Tan Sheet
Executive SummaryFDA is extending its warning letter "close-out" pilot program to learn more about its value, even as some experts grumble that the program may not be all it was cracked up to be.
You may also be interested in...
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
ORA sets a 2012 priority of improving the efficiency of the recall process to help reach its overall enforcement and compliance goal of preventing public health emergencies.